Shanghai Kinetic Medical Co., Ltd (SHE:300326)

Shanghai Kinetic Medical Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Net Income	179.22	134.89	-105.57	112.54	-21.28	161.78
Depreciation & Amortization	67.06	67.06	69.52	65.83	60.9	56.81
Other Amortization	14.53	14.53	12.93	12.16	13.38	11.81
Loss (Gain) From Sale of Assets	-0.26	-0.26	0.1	0.37	0.21	-1.6
Asset Writedown & Restructuring Costs	0.38	0.38	2.91	0.58	200	149.4
Loss (Gain) From Sale of Investments	-82.83	-82.83	193.26	-30.63	28.9	-47.79
Provision & Write-off of Bad Debts	-	-	-	-8.96	19.66	11.5
Other Operating Activities	8.41	44.65	32.67	23.38	11.85	38.82
Change in Accounts Receivable	13.87	13.87	-60.96	-214.81	149.93	45.61
Change in Inventory	-13.82	-13.82	-29.1	-21.89	-49.65	-60.62
Change in Accounts Payable	11.64	11.64	67.22	336.82	-174.18	38.11
Change in Other Net Operating Assets	5.62	5.62	2.38	-	-	-26.98
Operating Cash Flow	197.18	189.09	157.75	274.26	236.76	378.16
Operating Cash Flow Growth	6.15%	19.86%	-42.48%	15.84%	-37.39%	32.72%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Capital Expenditures	-43.88	-66.2	-82.84	-53.79	-41.45	-49.21
Sale of Property, Plant & Equipment	4.8	4.58	0.29	0.49	0.84	4.87
Cash Acquisitions	5.4	-	-	-	-	-64.73
Divestitures	155.03	155.33	-	9.37	1.4	30.5
Investment in Securities	-325.77	-430.08	-509.42	-168.58	-132.14	-37.69
Other Investing Activities	86.36	70.91	69.64	11.85	8.59	7.04
Investing Cash Flow	-120.13	-267.53	-522.33	-186.67	-163.78	-109.22

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Long-Term Debt Issued	-	225.67	310.26	175.7	172.82	293.08
Long-Term Debt Repaid	-	-239.45	-196.97	-346.01	-215.42	-456.71
Net Debt Issued (Repaid)	11.05	-13.79	113.29	-170.31	-42.6	-163.62
Common Dividends Paid	-3.42	-4.6	-46.14	-5.11	-47.23	-54.86
Other Financing Activities	10.79	14.62	2.71	-1.49	-14.26	-20.47
Financing Cash Flow	18.43	-3.77	69.86	-176.91	-104.09	-238.95

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Foreign Exchange Rate Adjustments	-5.17	-3.63	0.85	1.67	11.97	-3.03
Net Cash Flow	90.31	-85.83	-293.87	-87.64	-19.14	26.96

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Free Cash Flow	153.3	122.88	74.91	220.47	195.3	328.94
Free Cash Flow Growth	68.01%	64.04%	-66.02%	12.89%	-40.63%	28.84%
Free Cash Flow Margin	17.64%	12.76%	7.61%	23.06%	16.75%	25.93%
Free Cash Flow Per Share	0.21	0.17	0.10	0.31	0.27	0.46
Levered Free Cash Flow	238.03	109.43	55.1	190.28	160.13	-135.88
Unlevered Free Cash Flow	241.53	114.1	59.27	194.38	168.96	-121.71

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash Interest Paid	1.33	1.33	0.54	0.18	0.85	2.31
Cash Income Tax Paid	64.59	47.38	36.17	63.87	131.29	123.06
Change in Working Capital	10.67	10.67	-48.06	98.99	-76.86	-2.57

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 14, 2026

Data Sources Report a data error